Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study

Min Hu, Qinghua Xu, Shuangyan Yang, Shuiyun Han, Yaoyao Zhu, Qingren Lin, Xiaojiang Sun, Hui Liu, Yaping Xu